US News

Biogen Alzheimer’s drug hits roadblocks with some hospitals, insurers

Published by

By Deena Beasley (Reuters) -Biogen Inc’s Alzheimer’s drug, the first new treatment for the memory-robbing disease in nearly 20 years, hit new barriers on Thursday with some large hospitals declining to use it and health insurers delaying a decision while awaiting coverage terms from Medicare. Cleveland Clinic, one of the country’s best-known health systems, and New York’s Mount Sinai Health System on Thursday confirmed they had decided not to carry the new drug, called Aduhelm. “The tide turned on Friday when the inspector general investigation was announced, and the potential allegation of ir…

Read More

Facebook Comments

Check Also

Haiti police say former Supreme Court judge suspect in president’s killing

Published by Reuters PORT-AU-PRINCE (Reuters) – Haitian police ...